EMR already had >75% which even with the restrictions imposed by the TOP, EMR had full control including being able to pass special resolutions (is my understanding). Whilst waiting for the updated report, including the experts report on the value given to the Chinese shareholders V the other minority shareholders, there was no impetus to accept the offer, it HAD to remain open until 10 days after that report, and actually there was a reason to stay a Bullzeye holder, with a chance that further recompense would be the outcome of the report.
Once the updated report was out, it was accept the offer or not. And with no clear liquidity option visible in the future, accept was the option chosen by virtually everyone.
EMR Price at posting:
$3.46 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)